Research Insight

Dr. Fortuna says payers should consider expand their perspectives on improving the healthcare system by adopting the use of the tools, methodologies and quality improvement professionals (engineers) that other industries have with great success as recommended in the May...

Developed by Pfizer Global Research and Development, capravirine is a Non-Nuclesoide Reverse Transcriptase Inhibitor (NNRTI) that was under development for the treatment of patients infected with the Human Immunodeficiency Virus (HIV). It was indicated for patients with HIV/AIDS who...

We recycle a lot of things — paper, plastic, metal, blood. Yes, blood. During some surgeries, operating room personnel try to capture as much blood as possible and return the red blood cells to your system, instead of, or...

Abraxane (albumin-bound paclitaxel for injectable suspension) is an intravenous injection indicated for the treatment of metastatic pancreatic cancer. The drug was originally developed by Abraxis BioScience, which was acquired by Celgene Corporation in October 2010. Celgene...

Zonegran (Zonisamide) is an anti-epileptic drug indicated for the treatment of partial seizures in adults with epilepsy with or without secondary generalisation. The drug was originally discovered and developed by Dainippon Pharmaceutical (now Dainippon Sumitomo Pharma)....

Developed by Alizyme, a specialist biopharmaceutical company in collaboration with Takeda Pharmaceutical, cetilistat (ATL-962) is an experimental treatment for obesity. Cetilistat restricts pancreatic lipases and acts as an agent to treat obesity and related diabetes or dyslipidemia. ...

After discovering a potential molecular "target" for leukemia, Australian researchers say a drug to fight the disease is "in their sights," although it is still very early days. Writing in the journal Blood, they describe how the interaction of...